Screener
UroGen Pharma URGN Jelmyto — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $72,456 | $24,215 | $123,415 | $44,469 |
| Cost of revenue | 6,572 | 3,550 | 10,711 | 5,880 |
| Gross profit | 65,884 | 20,665 | 112,704 | 38,589 |
| Operating expenses: | ||||
| Research and development expenses | 17,336 | 18,914 | 32,933 | 38,785 |
| Selling, general and administrative expenses | 48,437 | 43,199 | 99,923 | 78,166 |
| Operating income (loss) | 111 | (41,448) | (20,152) | (78,362) |
| Financing on prepaid forward obligation | (4,545) | (4,644) | (9,051) | (9,227) |
Item 1. Financial Statements.
FAQ
- What is UroGen Pharma's jelmyto — revenue?
- UroGen Pharma (URGN) reported jelmyto — revenue of $22.03M in Q2 2026.
- How has UroGen Pharma's jelmyto — revenue changed year-over-year?
- UroGen Pharma's jelmyto — revenue decreased by 9.0% year-over-year, from $24.22M to $22.03M.
- What is the long-term trend for UroGen Pharma's jelmyto — revenue?
- Over 4 years (2021 to 2025), UroGen Pharma's jelmyto — revenue has grown at a 18.3% compound annual growth rate (CAGR), from $48.04M to $93.99M.
- What does jelmyto — revenue mean?
- This metric represents the gross revenue generated from the sale of a specific product or service, net of any sales-related taxes collected on behalf of government authorities. It serves as the primary indicator of commercial adoption and market demand for the product segment. By excluding taxes, it provides a standardized view of the top-line performance that is comparable across different jurisdictions and reporting periods.
Ask your AI about UroGen Pharma's jelmyto — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude